WHO I AM
I have an established track record of excellence working for award-winning advertising agencies in NYC for 15 years, developing compelling omnichannel campaigns from soup to nuts. I can traverse the most complex conditions and effortlessly bridge disciplines, nurturing smarter creative, fostering efficient workflows, and integrating new technologies to generate exceptional results for my clients.
I believe the best creative work doesn’t just look good - it solves real human problems.
In healthcare especially, complexity is the biggest barrier to connection. My focus is on turning that complexity into clear, compelling narratives that people can actually understand and act on.
WHAT I BRING
Strategic thinking grounded in real business problems
Fresh creative vision that goes beyond the status quo
Hands-on, ego-free leadership from the master vision to the smallest detail
Passion and dedication to improving outcomes for clinicians and patients alike
WHAT THEY SAY
Lauren is a rare blend of leadership, humility, and creativity. She is a case study unto herself – a force of nature with a giant heart who has a way of surmounting the most difficult tasks with a combination of strategy, artistry, and honesty. Lauren not only brings the vision – she completely owns every aspect of the process. Her teams and clients love her and she is an absolute dynamo.
– James Buonantuono | SVP, Head of Creative at S50 Agency –
CASE STUDIES
Nubeqa (Bayer)
We put the PRO in prostate
CHALLENGE
With the approval of a third indication, NUBEQA needed to re-enter a competitive prostate cancer market with a clearer, more compelling story– one that could resonate across HCPs, patients, and caregivers while differentiating from entrenched competitors.
INSIGHT
In a crowded category, clinical data alone isn’t enough. Trust is built by connecting efficacy to real-life impact, bridging rational proof with emotional relevance across every audience touchpoint.
SOLUTION
I led the creative direction to reposition the brand and unify its presence across channels through a comprehensive design system. We leveraged new AI technology to quickly generate and test several animatic concepts for regulatory review, drastically decreasing churn and production time. I developed two brand heroes to reflect the patient population and embody our core message: LIFE CHANGES... WHAT YOU LOVE DOESN'T HAVE TO. The rollout was supported by an influencer partnership with NFL superstar Tony Romo to broaden reach and cultural relevance.
IMPACT
Repositioned NUBEQA as Bayer’s fastest-growing asset, driving over $2.7B in revenue (a 57% year-over-year increase), significantly expanding Nubeqa's market footprint following relaunch.
RECOGNITION
DTC Perspectives Award for Best in TV (Bronze)
SCOPE
Brand identity redevelopment and campaign creation for relaunch (HCP & patient) including broadcast, digital, print, social, CRM, docu videos, KOLs, sales materials, and influencer activation.
Spinraza (Biogen)
When healthcare becomes human
CHALLENGE
Spinal muscular atrophy (SMA) is a rare, genetically complex disease that is difficult—especially for children—to explain. Existing resources failed to support these conversations in an accessible, age-appropriate way.
INSIGHT
Children don’t need clinical explanations—they need stories. By translating complex medical realities into a relatable, emotionally resonant narrative, we can foster understanding and empathy.
SOLUTION
We created a behavior-change tool: Zac’s Play Day, is a first-of-its-kind storybook designed to help children communicate their experience with SMA. In collaboration with illustrator Charles Santoso, we combined a warm, engaging narrative with medically accurate visuals ensuring both authenticity and accessibility. This was supported by a disease education ecosystem –Together In SMA– and subsequent product launch.
IMPACT
Adopted in classrooms and homes worldwide, Zac’s Play Day sparked meaningful conversations beyond the disease—encouraging empathy, acceptance, and inclusion.
RECOGNITION
Cannes Lions Silver, MM+M Gold, MANNY Gold; described by judges as "fantastic, brilliant, amazing. This industry needs more Zacs."
SCOPE
Disease education and full campaign development for launch (HCP & patient) including digital, print, social, video, MOA/MOD, congress, and storybook.
Fabhalta (Novartis)
Seven agencies. Six months. Zero room for failure
CHALLENGE
FABHALTA entered the market as a first-in-class Factor B inhibitor with potential across multiple rare diseases, including PNH and IgA nephropathy. The complexity wasn’t just scientific, it was operational. Launch required aligning multiple indications, audiences, and agency partners at speed, all while building awareness in low-prevalence, highly nuanced disease states.
INSIGHT
In rare disease, success hinges on two things: clarity and coordination. To break through, we needed to simplify complex science while orchestrating a unified, high-velocity ecosystem across every stakeholder and touchpoint.
SOLUTION
Through a pioneering multi-agency collaboration with Merkley + Partners, Propeller, HCG, Maslansky, Snow, and Apelphi, we delivered 150+ assets in just 6 months. At congress, we brought the science to life through two custom-built experiences featuring Hypervsn and Proto holographic technology, alongside the immersive “Storm Room”—a groundbreaking installation designed to viscerally convey disease burden and urgency.
IMPACT
The campaign generated over 70 million impressions, nearly 200,000 site visitors, and engagement rates as high as 71%, significantly increasing awareness and understanding across both HCP and patient audiences. The integrated launch approach enabled rapid market readiness across indications, setting a new standard for speed, scale, and collaboration in rare disease commercialization.
RECOGNITION
Cited in trade coverage including MM+M and PharmaLive as being immersive, out-of-the-category storytelling.
SCOPE
Launch campaign development (HCP for PNH indication), including digital, print, video, KOLs, social, CRM, sales materials, and congress.
Tabrecta (Novartis)
Making an invisible mutation impossible to ignore
CHALLENGE
Tabrecta entered the market as the first-and-only FDA-approved therapy targeting MET exon 14 mutations in metastatic NSCLC—a rare but aggressive subset affecting just 3–4% of patients. Despite strong clinical efficacy, adoption was limited by low biomarker awareness and inconsistent genomic testing, leaving thousands of eligible patients undiagnosed and untreated.
INSIGHT
You can’t drive demand for a therapy if patients aren’t identified.
Unlocking growth required shifting the conversation from treatment to detection, making biomarker testing the gateway to care.
SOLUTION
Launch campaign anchored in disease education and biomarker activation featuring the visually disruptive "METex Monster"—a striking 3D visualization designed to personify an invisible mutation and make genomic profiling tangible (and urgent) for both HCPs and patients.
IMPACT
The campaign helped elevate METex14 from an under-recognized biomarker to a prioritized focus in metastatic NSCLC. This positioned Tabrecta as a category-defining precision therapy and the leading prescribed treatment for METex14 NSCLC, while helping drive uptake in a previously unseen population of ~4,000–5,000 patients annually.
RECOGNITION
My favorite tumor monster I have ever personally worked on.
SCOPE
Disease education and full campaign development for launch (HCP), including digital, print, video, KOLs, MOA/MOD, social, CRM, sales materials, congress.
WHERE I'VE BEEN
S50 Agency / BGB Group | New York City
Creative Director, 2025 – 2026
DDB Health / Remedy Edge | New York City
VP, Associate Creative Director, 2019 – 2024
CDM NY | New York City
Vice President, Art Group Supervisor, 2012 – 2019
LBi / Digitas | New York City
Senior Art Director, 2010 – 2012
WHAT I DO
Omnichannel Advertising & Marketing
AI Workflow Integration & Optimization
Omnichannel Campaign Development
Creative Concepting
New Business Pitching
Branding & Visual Identity
Scientific Storytelling & Clinical Data Viz
Market Research Facilitation
Medical Legal Regulatory (MLR) Review
Team Building & Cross-discipline Leadership
Client Relationship Building
EXPERTISE
HEALTHCARE | Oncology, Rare Disease, Neurology, Hematology, Autoimmune, Gastrointestinal, Cardiovascular, Dermatology, Muscular Disorders, Infectious Disease, Ophthalmology, Mental Health, Women's Health
CONSUMER | Fashion & Beauty, Sports, Auto, Finance, Real Estate, Communications, Music, Tech, Travel, Food & Beverage
CLIENTS
AWARDS
